LMAT News and Press, LeMaitre Vascular Inc. From 05/12/20

BURLINGTON, Mass., May 12, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the UBS Virtual Global Healthcare Conference on Wednesday, May 20, 2020, at 8:20 AM EDT. LeMaitre Vascular is ...

LeMaitre Vascular, Inc. (LMAT) Q1 2020 Results Conference Call April 30, 2020 05:00 PM ET Company Participants JJ Pellegrino - Chief Financial Officer George LeMaitre - Chairman & CEO David Roberts - President Conference Call Participants Jim Sidoti - Sidoti and Company...

Image source: The Motley Fool. LeMaitre Vascular   (NASDAQ: LMAT) Q1 2020 Earnings Call Apr 30, 2020 , 5:00 p.m. ET Operator Continue reading

LeMaitre Vascular (NASDAQ: LMAT ): Q1 GAAP EPS of $0.16 in-line. More news on: LeMaitre Vascular, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

BURLINGTON, Mass., April 30, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2020 results and announced a $0.095/share quarterly dividend. Q1 2020 Results Record sales of $30.6mm, +7% (-1% organic)...

The past two months on the stock market have taught us a humbling lesson: we can’t predict the future. In light of such volatility and dividend cuts/suspensions, it is time for all of us to review our investing strategy and make sure it can weather this and future storms. Right now, you...

I'll wait until everything settles and then I'll start investing." Besides " this market is going to crash and burn to ashes." This is probably the line I've read the most over the last 6 weeks. I will not address the latter but will concentrate on the eternal "when it's the right time...

BURLINGTON, Mass., April 13, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, announced today Q1 2020 preliminary, unaudited results and withdrew prior annual guidance for 2020 due to the potential impact of COVID-19...

One of the things that has been at the forefront of my mind during the recent turmoil is that I can't assume stocks are cheap just because they have gone down. Many (most?) stocks deserved to go down because they were unrealistically high pre-corona virus chaos. Taking a peak at a number of st...

Short Take Silk Road Medical ( SILK ) went public on April 4, 2019 and recently reported calendar year 2019 financial results. The firm produces carotid artery medical devices to protect patients from stroke. SILK expects strong growth in 2020, but that may be attenuated by unforeseen ef...